ask="23.72"
ask_size="600"
average_daily_volume="439257"
bid="16.26"
bid_size="200"
book_value="3.21"
change="-0.04"
change_from_200_day_moving_average="5.29"
change_from_50_day_moving_average="0.34"
change_from_52_week_high="-3.07"
change_From_52_week_low="14.66"
change_in_percent="-0.19%"
close="20.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="7150000"
high="20.98"
high_52_weeks="23.75"
last_trade_date="3/15/2017"
last_trade_price="20.68"
last_trade_size="2364"
last_trade_time="4:00pm"
low="20.25"
low_52_weeks="6.02"
market_capitalization="205.83M"
moving_average_200_day="15.39"
moving_average_50_day="20.34"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="32.60"
open="20.63"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+34.41%"
percent_change_from_50_day_moving_average="+1.69%"
percent_change_from_52_week_high="-12.93%"
percent_change_from_52_week_low="+243.52%"
previous_close="20.72"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.46"
price_per_sales="3648.47"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.71"
stock_exchange="NGM"
symbol="ZYNE"
volume="205665"
weeks_range_52="6.02 - 23.75"
